Invention Grant
- Patent Title: Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
-
Application No.: US16222380Application Date: 2018-12-17
-
Publication No.: US10696713B2Publication Date: 2020-06-30
- Inventor: Guoqiang Wang , Yat Sun Or , Ruichao Shen , Jiang Long , Peng Dai , Xuechao Xing , Jing He
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07J41/00
- IPC: C07J41/00 ; C07J43/00 ; C07J9/00 ; C07J51/00
Abstract:
The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Public/Granted literature
- US20190194245A1 BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF Public/Granted day:2019-06-27
Information query
